Healio

Gut microbiome restored, 6-month safety confirmed with Rebyota via colonoscopy

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most patients (92.7%) with recurrent C. difficile ...
Business Wire

Retrospective Analysis of Data Evaluating Safety and Efficacy of REBYOTA™ (fecal microbiota, live – jslm) in a Real-World Patient Population with Comorbidities and Risk ...

REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for recurrent C. diff ...
Healio

VIDEO: Rebyota safe, effective when given via colonoscopy for recurrent C. difficile

Please provide your email address to receive an email when new articles are posted on . “C. difficile is a major problem for people in the United States; it is the most common health care-associated ...
Morningstar

Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal microbiota, live – jslm)

FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong drug supply and dedicated manufacturing facility Since launch, Ferring created REBYOTA @ Home ...